Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 868,404,096
  • Shares Outstanding, K 950,405
  • Annual Sales, $ 34,124 M
  • Annual Income, $ 5,240 M
  • 60-Month Beta 0.42
  • Price/Sales 25.02
  • Price/Cash Flow 116.33
  • Price/Book 61.84
Trade LLY with:

Options Overview Details

View History
  • Implied Volatility 39.26% ( -0.26%)
  • Historical Volatility 22.04%
  • IV Percentile 95%
  • IV Rank 51.49%
  • IV High 55.08% on 08/05/24
  • IV Low 22.46% on 06/28/24
  • Put/Call Vol Ratio 0.75
  • Today's Volume 20,400
  • Volume Avg (30-Day) 35,520
  • Put/Call OI Ratio 0.98
  • Today's Open Interest 290,636
  • Open Int (30-Day) 295,354

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 4.54
  • Number of Estimates 9
  • High Estimate 5.01
  • Low Estimate 4.27
  • Prior Year 0.10
  • Growth Rate Est. (year over year) +4,440.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
858.81 +7.09%
on 09/30/24
942.35 -2.40%
on 09/13/24
+11.47 (+1.26%)
since 09/09/24
3-Month
747.55 +23.03%
on 08/05/24
972.53 -5.43%
on 08/22/24
-12.76 (-1.37%)
since 07/09/24
52-Week
547.61 +67.96%
on 10/31/23
972.53 -5.43%
on 08/22/24
+347.98 (+60.86%)
since 10/09/23

Most Recent Stories

More News
Why Eli Lilly Was Such a Healthy Stock Today

The pharmaceutical giant's weight loss medication Zepbound was in the spotlight again Tuesday.

LLY : 919.74 (+0.66%)
Pfizer Receives $1 Billion From Starboard Value, Stock Rises

Shares of Pfizer PFE rose 2.17% on Oct. 7 after a report from The Wall Street Journal stated that activist investor Starboard Value has taken a roughly $1 billion stake in the company.Investors cheered...

NVO : 117.00 (-0.17%)
LLY : 919.74 (+0.66%)
PFE : 30.19 (+3.46%)
Hims & Hers Stock Joins S&P 600: Is More Upside on the Horizon?

There is now a new reason to look into Hims & Hers stock for additional upside, including the new addition to the S&P 600 index alongside double-digit growth.

HIMS : 18.73 (-0.11%)
MSCI : 604.43 (+1.27%)
LLY : 919.74 (+0.66%)
Want to Invest in the Weight Loss Boom? Consider Buying These 2 Stocks

Investing in the most popular players in the space isn't the only valid approach.

AZN : 77.50 (+0.83%)
LLY : 919.74 (+0.66%)
AMGN : 322.41 (+1.49%)
With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?

Growth for its GLP-1 weight loss drugs continues to be robust.

HIMS : 18.73 (-0.11%)
LLY : 919.74 (+0.66%)
Zacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer

For Immediate ReleaseChicago, IL – October 8, 2024 – Today, Zacks Equity Research Eli Lilly LLY, AstraZeneca AZN, Pfizer PFE, Sanofi SNY and Bayer BAYRY.Industry: Big PharmaLink: https://www.zacks.com/commentary/2346520/5-large-drug-stocks-to-watch-from-a-thriving-industryThe...

BAYRY : 7.4950 (-6.89%)
AZN : 77.50 (+0.83%)
LLY : 919.74 (+0.66%)
PFE : 30.19 (+3.46%)
SNY : 55.15 (+0.55%)
Billion-Dollar News for Eli Lilly Stock Investors

Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.

NVO : 117.00 (-0.17%)
LLY : 919.74 (+0.66%)
GS : 505.18 (+1.73%)
Should JNJ Stock Be in Your Portfolio Ahead of Q3 Earnings?

Johnson & Johnson JNJ will report its third-quarter earnings on Oct. 15. The Zacks Consensus Estimate for sales and earnings is pegged at $22.19 billion and $2.19 per share, respectively. The Zacks Consensus...

JNJ : 160.65 (+0.60%)
LLY : 919.74 (+0.66%)
KVUE : 21.53 (-1.46%)
Why Pfizer Stock Popped on Monday

Can Starboard Value and former CEO Ian Read save Pfizer stock?

LLY : 919.74 (+0.66%)
PFE : 30.19 (+3.46%)
5 Large Drug Stocks to Watch From a Thriving Industry

The drug and biotech industry has done well this year, driven by increased mergers and acquisitions (M&A), the launch of promising new medicines and pipeline successes. Obesity drugs of Novo Nordisk and...

BAYRY : 7.4950 (-6.89%)
AZN : 77.50 (+0.83%)
LLY : 919.74 (+0.66%)
PFE : 30.19 (+3.46%)
SNY : 55.15 (+0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure...

See More

Key Turning Points

3rd Resistance Point 932.74
2nd Resistance Point 927.05
1st Resistance Point 923.39
Last Price 919.74
1st Support Level 914.04
2nd Support Level 908.35
3rd Support Level 904.69

See More

52-Week High 972.53
Last Price 919.74
Fibonacci 61.8% 810.21
Fibonacci 50% 760.07
Fibonacci 38.2% 709.93
52-Week Low 547.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar